Pharmaceutical News

RSS

Study identifies factors that may contribute to use of PIMs at the end of life

A recent interview study has uncovered factors that may contribute to the use of potentially inappropriate medications (PIMs) at the end of life.

18 Oct 2016

EKF Diagnostics’ novel diabetic biomarker test successfully externally verified

EKF, announces that its Glycated Serum Protein LiquiColor diabetic biomarker test has been verified for use on the Siemens Vista chemistry analyzer.

From EKF Diagnostics 18 Oct 2016

Porvair announce record sales of microplate evaporators

Porvair Sciences has confirmed that 2016 will see record sales of its Ultravap and Minivap ranges of blowdown evaporators to laboratories worldwide. The company first began selling nitrogen blowdown evaporators for microplate sample drying in 1999.

From Porvair Sciences Limited 18 Oct 2016

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Anti-inflammatory drugs similar to those used to treat conditions such as rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression, concludes a review led by the University of Cambridge, which further implicates our immune system in mental health disorders.

18 Oct 2016

Cold medication could suppress spread of bladder cancers

Hokkaido University researchers have discovered that a nonsteroid anti-inflammatory drug used for treating colds suppresses the spread of bladder cancers and reduces their chemoresistance in mice, raising hopes of a future cure for advanced bladder cancers.

17 Oct 2016

Moderate calcium intake not linked to coronary artery calcification, says UAB cardiologist

A study recently published in the Journal of the American Heart Association is prompting headlines like "Calcium supplements might hurt your heart."

17 Oct 2016

Cambridge Cognition announces new contracts for CANTAB Connect for HAL testing of investigational drugs

Cambridge Cognition today announced a series of new contracts for its cloud-based CANTAB Connect software platform for the Human Abuse Liability (HAL) testing of investigational drugs.

17 Oct 2016

Study quantifies burden of adverse drug reactions in general adult population

In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.

17 Oct 2016

New stem cell-based strategy may help predict heart-damaging effects of drugs

Coaxing stem cells from patients to become heart cells may help clinicians personalize drug treatments and prevent heart-related toxicity.

17 Oct 2016

Scientists develop software package to predict chemical properties of molecules

Scientists from MIPT's Research Center for Molecular Mechanisms of Aging and Age-Related Diseases together with Inria research center, Grenoble, France have developed a software package called Knodle to determine an atom's hybridization, bond orders and functional groups' annotation in molecules.

17 Oct 2016

Wayne State receives NIH grant to study use of opioid addiction drug to fight relapse in recovering addicts

A team led by Wayne State University School of Medicine researcher Mark Greenwald, Ph.D., will use a four-year, $2,279,723 competitively renewed grant from the National Institute on Drug Abuse of the National Institutes of Health to explore whether the opioid addiction treatment medication buprenorphine can decrease the magnitude and/or duration of responses to stressors faced by recovering addicts.

15 Oct 2016

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Scientists at the National Institutes of Health and Emory University have experimentally induced sustained remission of SIV, the simian form of HIV, in infected monkeys.

14 Oct 2016

Mild sedative could reduce risk of post-operative delirium

A mild sedative could greatly reduce the risk of people experiencing delirium after an operation, according to new research.

14 Oct 2016

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

A study conducted by Canadian and Australian researchers shows that nearly everywhere in Canada, the provinces and territories impose obstacles to reimbursement of new direct-acting antivirals (DAA) to treat hepatitis C by because of their cost.

14 Oct 2016

Knowingly taking placebo pills can help alleviate chronic back pain, study finds

Conventional medical wisdom has long held that placebo effects depend on patients' belief they are getting pharmacologically active medication.

14 Oct 2016

UA study questions safety and efficacy of selenium in reducing risk of colorectal cancer

A 12-year study led by a team of University of Arizona Cancer Center researchers is bringing into question the safety and efficacy of selenium, a popular nutritional supplement touted to combat and reduce the risk of colorectal cancer.

14 Oct 2016

Common beta-blocker prescribed for heart conditions has anti-cancer properties, study shows

Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant anti-cancer properties, say researchers in a new clinical study published in ecancermedicalscience.

14 Oct 2016

TSRI scientists receive NIH grant to develop memory-erasing medication for addiction

In a development that brings the world one step closer to a time when destructive addiction-fueling memories can be erased with a single treatment, scientists from the Florida campus of The Scripps Research Institute have been given a grant by the National Institutes of Health through the Blueprint Neurotherapeutics Network and the National Institute of Drug Abuse.

13 Oct 2016

Study links repeated SSRIs during pregnancy to childhood language disorders

The use of selective serotonin reuptake inhibitors at least twice during pregnancy may be associated with an increased risk of offspring developing a speech and/or language disorder, according to a study from Columbia University.

13 Oct 2016

Scientists develop smart drug that safely removes fat from liver and blood vessels

Scientists from the Technical University of Munich and Helmholtz Zentrum München have developed a ‘smart’ drug that safely clears the liver of fat and prevents blood vessels from clogging up.

13 Oct 2016

Pharmaceutical News

Study identifies factors that may contribute to use of PIMs at the end of life

EKF Diagnostics’ novel diabetic biomarker test successfully externally verified

Porvair announce record sales of microplate evaporators

Anti-inflammatory drugs may improve severity of depressive symptoms, study finds

Cold medication could suppress spread of bladder cancers

Moderate calcium intake not linked to coronary artery calcification, says UAB cardiologist

Cambridge Cognition announces new contracts for CANTAB Connect for HAL testing of investigational drugs

Study quantifies burden of adverse drug reactions in general adult population

New stem cell-based strategy may help predict heart-damaging effects of drugs

Scientists develop software package to predict chemical properties of molecules

Wayne State receives NIH grant to study use of opioid addiction drug to fight relapse in recovering addicts

Scientists at NIH and Emory University induce sustained remission in SIV-infected monkeys

Mild sedative could reduce risk of post-operative delirium

Many Canadian territories restrict access to medications for treating hepatitis C, study finds

Knowingly taking placebo pills can help alleviate chronic back pain, study finds

UA study questions safety and efficacy of selenium in reducing risk of colorectal cancer

Common beta-blocker prescribed for heart conditions has anti-cancer properties, study shows

TSRI scientists receive NIH grant to develop memory-erasing medication for addiction

Study links repeated SSRIs during pregnancy to childhood language disorders

Scientists develop smart drug that safely removes fat from liver and blood vessels

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News